Cargando…
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies
Meningiomas are a heterogeneous group of tumors, defined histo-pathologically by World Health Organization (WHO) grading. The WHO grade of meningiomas does not always correlate with clinical aggressiveness. Despite maximal surgical resection and adjuvant radiation, a subset of tumors are clinically...
Autores principales: | Nazem, Ahmad A., Ruzevick, Jacob, Ferreira, Manuel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733625/ https://www.ncbi.nlm.nih.gov/pubmed/33346248 http://dx.doi.org/10.18632/oncotarget.27841 |
Ejemplares similares
-
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
por: Halabi, Reem, et al.
Publicado: (2023) -
Review Insights on Salivary Proteomics Biomarkers in Oral Cancer Detection and Diagnosis
por: Umapathy, Vidhya Rekha, et al.
Publicado: (2023) -
Implementation of proteomic biomarkers: making it work
por: Mischak, Harald, et al.
Publicado: (2012) -
Epigenetics of Meningiomas
por: Murnyák, Balázs, et al.
Publicado: (2015) -
Guest Editorial: Epigenetics: Environmental Instructions for the Genome
por: Wade, Paul A., et al.
Publicado: (2006)